dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Shaw, Alice Tsang |
dc.contributor.author | Johnson, Melissa L. |
dc.contributor.author | Navarro Mendivil, Alejandro |
dc.contributor.author | Gainor, Justin F. |
dc.contributor.author | Thurm, Holger |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Bauer, Todd |
dc.date.accessioned | 2021-10-26T07:11:19Z |
dc.date.available | 2021-10-26T07:11:19Z |
dc.date.issued | 2020-02 |
dc.identifier.citation | Bauer TM, Shaw AT, Johnson ML, Navarro A, Gainor JF, Thurm H, et al. Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer. Target Oncol. 2020 Feb;15:55–65. |
dc.identifier.issn | 1776-260X |
dc.identifier.uri | https://hdl.handle.net/11351/6462 |
dc.description | Lorlatinib; Cáncer de pulmón |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Targeted Oncology;15 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Disease Progression |
dc.title | Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s11523-020-00702-4 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | progresión de la enfermedad |
dc.relation.publishversion | https://doi.org/10.1007/s11523-020-00702-4 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Bauer TM, Johnson ML] Sarah Cannon Cancer Research Institute/Tennessee Oncology, PLLC, 250 25th Ave N, Nashville, TN 37203, USA. [Shaw AT, Gainor JF] Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA. [Navarro A, Felip E] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Thurm H] Pfzer Oncology, 10777 Science Center Dr, La Jolla, CA, USA |
dc.identifier.pmid | 32060867 |
dc.identifier.wos | 000514800300007 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |